CASI Pharmaceuticals Gross Profit 2012-2025 | CASI

CASI Pharmaceuticals gross profit from 2012 to 2025. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.

CASI Pharmaceuticals Annual Gross Profit (Millions of US $)
2024	$11
2023	$20
2022	$27
2021	$18
2020	$6
2019	$0
2018
2017
2016
2015	$0
2014	$0
2013
2012	$1
2011	$2

CASI Pharmaceuticals Quarterly Gross Profit (Millions of US $)
2025-09-30	$1
2025-06-30	$2
2025-03-31	$4
2024-12-31	$3
2024-09-30	$4
2024-06-30	$2
2024-03-31	$2
2023-12-31	$4
2023-09-30	$5
2023-06-30	$6
2023-03-31	$5
2022-12-31	$11
2022-09-30	$6
2022-06-30	$5
2022-03-31	$5
2021-12-31	$5
2021-09-30	$5
2021-06-30	$4
2021-03-31	$3
2020-12-31	$3
2020-09-30	$2
2020-06-30	$0
2020-03-31	$0
2019-12-31	$0
2019-09-30	$0
2019-06-30
2019-03-31
2018-12-31
2018-09-30
2018-06-30
2018-03-31
2017-12-31
2017-09-30
2017-06-30
2017-03-31
2016-12-31
2016-09-30
2016-06-30
2016-03-31
2015-12-31	$0
2015-09-30
2015-06-30	$0
2015-03-31	$0
2014-12-31
2014-09-30
2014-06-30
2014-03-31
2013-12-31
2013-09-30
2013-06-30
2013-03-31
2012-12-31
2012-09-30
2012-06-30
2012-03-31
2011-12-31	$2
2011-09-30
2011-06-30	$0
2011-03-31

Sector	Industry	Market Cap	Revenue
Medical	Medical - Drug Manufacturing	$0.013B	$0.029B
CASI Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It is focused on the acquisition, development and commercialization of proprietary therapeutics for the treatment of cancer and other diseases for the global markets, with a focus on China. The Company's products present antiangiogenic solutions to cancer, cardiovascular disease, and macular degeneration. CASI Pharmaceuticals Inc., formerly known as EntreMed, Inc., is headquartered in Rockville, Maryland.

Stock Name	Country	Market Cap	PE Ratio
Chugai Pharmaceutical (CHGCY)	Japan	$87.245B	33.14
Zoetis (ZTS)	United States	$54.919B	19.66
Takeda Pharmaceutical (TAK)	Japan	$50.943B	10.40
Daiichi Sankyo, - (DSNKY)	Japan	$42.301B	21.07
BeOne Medicines - (ONC)	Switzerland	$38.498B	204.10
Sandoz Group AG (SDZNY)	Switzerland	$32.476B	0.00
United Therapeutics (UTHR)	United States	$20.532B	18.07
Merck (MKKGY)	Germany	$19.360B	11.94
Shionogi (SGIOY)	Japan	$15.432B	14.17
Neurocrine Biosciences (NBIX)	United States	$13.187B	31.64
Summit Therapeutics (SMMT)	United States	$12.963B	0.00
Ionis Pharmaceuticals (IONS)	United States	$12.874B	0.00
IPSEN (IPSEY)	France	$12.596B	0.00
Madrigal Pharmaceuticals (MDGL)	United States	$11.217B	0.00
Orion OYJ (ORINY)	Finland	$10.204B	29.15
Eisai (ESAIY)		$8.586B	0.00
Ono Pharmaceutical (OPHLF)	Japan	$6.576B	20.00
Stevanato Group S.p.A (STVN)	Italy	$6.178B	34.58
Grifols, S.A (GRFS)	Spain	$6.078B	0.00
Crinetics Pharmaceuticals (CRNX)	United States	$5.154B	0.00
Hikma Pharmaceuticals Plc (HKMPF)	United Kingdom	$4.613B	0.00
Indivior (INDV)	United States	$4.251B	17.35
AMNEAL PHARMACEUTICALS, INC (AMRX)	United States	$4.077B	19.36
Corcept Therapeutics (CORT)	United States	$3.824B	41.31
NewAmsterdam Pharma (NAMS)	Netherlands	$3.613B	0.00
Centessa Pharmaceuticals (CNTA)	United Kingdom	$2.987B	0.00
Hypermarcas (HYPMY)	Brazil	$2.784B	19.11
Catalyst Pharmaceuticals (CPRX)	United States	$2.747B	8.76
Dyne Therapeutics (DYN)	United States	$2.434B	0.00
Soleno Therapeutics (SLNO)	United States	$2.230B	0.00
Ocular Therapeutix (OCUL)	United States	$2.222B	0.00
Avadel Pharmaceuticals (AVDL)	Ireland	$2.098B	0.00
Guardian Pharmacy Services (GRDN)	United States	$1.979B	38.12
Aurinia Pharmaceuticals Inc (AUPH)	Canada	$1.976B	23.42
Harrow (HROW)	United States	$1.748B	107.25
Ardelyx (ARDX)	United States	$1.711B	0.00
Enliven Therapeutics (ELVN)	United States	$1.528B	0.00
Oruka Therapeutics (ORKA)	United States	$1.517B	0.00
Collegium Pharmaceutical (COLL)	United States	$1.495B	7.40
BioCryst Pharmaceuticals (BCRX)	United States	$1.422B	84.38
Amylyx Pharmaceuticals (AMLX)	United States	$1.384B	0.00
Relay Therapeutics (RLAY)	United States	$1.376B	0.00
Evotec AG (EVO)	Germany	$1.374B	0.00
Xeris Biopharma Holdings (XERS)	United States	$1.279B	0.00
Savara (SVRA)	United States	$1.205B	0.00
ARS Pharmaceuticals (SPRY)	United States	$1.118B	0.00
Cronos Group (CRON)	Canada	$1.032B	0.00
Theravance Biopharma (TBPH)	United States	$1.030B	43.26
Xencor (XNCR)	United States	$0.995B	0.00
Esperion Therapeutics (ESPR)	United States	$0.789B	0.00
KalVista Pharmaceuticals (KALV)	United States	$0.755B	0.00
Ironwood Pharmaceuticals (IRWD)	United States	$0.755B	17.85
Nektar Therapeutics (NKTR)	United States	$0.744B	0.00
Rigel Pharmaceuticals (RIGL)	United States	$0.689B	6.15
ProKidney (PROK)	United States	$0.689B	0.00
Bioventus (BVS)	United States	$0.637B	13.05
Lexeo Therapeutics (LXEO)	United States	$0.542B	0.00
Organogenesis (ORGO)	United States	$0.518B	0.00
Elite Pharmaceuticals (ELTP)	United States	$0.516B	0.00
Lyell Immunopharma (LYEL)	United States	$0.504B	0.00
Zevra Therapeutics (ZVRA)	United States	$0.502B	0.00
Siga Technologies (SIGA)	United States	$0.473B	6.47
4D Molecular Therapeutics (FDMT)	United States	$0.449B	0.00
Altimmune (ALT)	United States	$0.418B	0.00
Aquestive Therapeutics (AQST)	United States	$0.417B	0.00
Nature's Sunshine Products (NATR)	United States	$0.392B	23.34
USANA Health Sciences (USNA)	United States	$0.371B	10.36
Akebia Therapeutics (AKBA)	United States	$0.366B	0.00
Avalo Therapeutics (AVTX)	United States	$0.318B	0.00
Profound Medical (PROF)	Canada	$0.304B	0.00
Relmada Therapeutics (RLMD)	United States	$0.298B	0.00
Achieve Life Sciences (ACHV)	Canada	$0.294B	0.00
Aclaris Therapeutics (ACRS)	United States	$0.294B	0.00
Silence Therapeutics (SLN)	United Kingdom	$0.279B	0.00
Larimar Therapeutics (LRMR)	United States	$0.276B	0.00
Fractyl Health (GUTS)	United States	$0.275B	0.00
OmniAb (OABI)	United States	$0.274B	0.00
Heron Therapeutics (HRTX)	United States	$0.271B	0.00
Protara Therapeutics (TARA)	United States	$0.254B	0.00
Aldeyra Therapeutics (ALDX)	United States	$0.249B	0.00
Journey Medical (DERM)	United States	$0.217B	0.00
Enlivex Therapeutics (ENLV)	Israel	$0.210B	0.00
Galectin Therapeutics (GALT)	United States	$0.198B	0.00
Tonix Pharmaceuticals Holding (TNXP)	United States	$0.190B	0.00
Century Therapeutics (IPSC)	United States	$0.188B	0.00
Minerva Neurosciences (NERV)	United States	$0.185B	0.00
MediWound (MDWD)	Israel	$0.183B	0.00
Innate Pharma SA (IPHYF)	France	$0.181B	0.00
Surrozen (SRZN)	United States	$0.177B	0.00
AleAnna (ANNA)	United States	$0.168B	0.00
Procaps Group, S.A (PROCF)	Luxembourg	$0.161B	0.00
Karyopharm Therapeutics (KPTI)	United States	$0.145B	0.00
Prelude Therapeutics (PRLD)	United States	$0.141B	0.00
Corbus Pharmaceuticals Holdings (CRBP)	United States	$0.139B	0.00
Context Therapeutics (CNTX)	United States	$0.138B	0.00
Incannex Healthcare (IXHL)	Australia	$0.132B	0.00
Unicycive Therapeutics (UNCY)	United States	$0.130B	0.00
Verrica Pharmaceuticals (VRCA)	United States	$0.128B	0.00
VAXART, INC (VXRT)	United States	$0.127B	0.00
Inhibikase Therapeutics (IKT)	United States	$0.126B	0.00
Pyxis Oncology (PYXS)	United States	$0.117B	0.00
Avita Medical (RCEL)	United States	$0.101B	0.00
Cassava Sciences (SAVA)	United States	$0.099B	0.00
Champions Oncology (CSBR)	United States	$0.098B	41.50
Cardiol Therapeutics (CRDL)	Canada	$0.097B	0.00
Vivani Medical (VANI)	United States	$0.093B	0.00
Gain Therapeutics (GANX)	United States	$0.086B	0.00
Korro Bio (KRRO)	United States	$0.085B	0.00
PolyPid (PYPD)	Israel	$0.070B	0.00
Cumberland Pharmaceuticals (CPIX)	United States	$0.070B	58.50
Dominari Holdings (DOMH)	United States	$0.068B	0.00
Assertio Holdings (ASRT)	United States	$0.066B	0.00
Plus Therapeutics (PSTV)	United States	$0.065B	0.00
Arch Biopartners (ACHFF)	Canada	$0.065B	0.00
Metagenomi (MGX)	United States	$0.065B	0.00
Rafael Holdings (RFL)	United States	$0.064B	0.00
NRx Pharmaceuticals (NRXP)	United States	$0.063B	0.00
PMV Pharmaceuticals (PMVP)	United States	$0.062B	0.00
Lipocine (LPCN)	United States	$0.058B	0.00
Lite Strategy (LITS)	United States	$0.055B	0.00
Acrivon Therapeutics (ACRV)	United States	$0.054B	0.00
Nutriband (NTRB)	United States	$0.052B	0.00
ElectroCore (ECOR)	United States	$0.050B	0.00
Talphera (TLPH)	United States	$0.048B	0.00
Telomir Pharmaceuticals (TELO)	United States	$0.046B	0.00
Reviva Pharmaceuticals Holdings (RVPH)	United States	$0.041B	0.00
FibroGen (FGEN)	United States	$0.039B	0.00
Wellgistics Health (WGRX)	United States	$0.038B	0.00
FibroGen (KYNB)	United States	$0.037B	0.00
Mural Oncology (MURA)	Ireland	$0.035B	0.00
Jupiter Neurosciences (JUNS)	United States	$0.032B	0.00
MARKER THERAPEUTICS, INC (MRKR)	United States	$0.029B	0.00
Natural Alternatives (NAII)	United States	$0.028B	0.00
SCYNEXIS (SCYX)	United States	$0.028B	0.00
TherapeuticsMD (TXMD)	United States	$0.024B	0.00
Klotho Neurosciences (KLTO)	United States	$0.024B	0.00
Scienture Holdings (SCNX)	United States	$0.022B	0.00
Inotiv (NOTV)	United States	$0.021B	0.00
Liminatus Pharma (LIMN)	United States	$0.021B	0.00
VYNE Therapeutics (VYNE)	United States	$0.019B	0.00
Iterum Therapeutics (ITRM)	Ireland	$0.018B	0.00
Citius Pharmaceuticals (CTXR)	United States	$0.018B	0.00
Vyome Holdings (HIND)	United States	$0.018B	0.00
Vivos Therapeutics (VVOS)	United States	$0.018B	0.00
Cosmos Health (COSM)	United States	$0.018B	0.00
Mannatech (MTEX)	United States	$0.014B	0.00
Tempest Therapeutics (TPST)	United States	$0.013B	0.00
Traws Pharma (TRAW)	United States	$0.013B	0.02
Phio Pharmaceuticals (PHIO)	United States	$0.013B	0.00
BioLineRx (BLRX)	Israel	$0.012B	0.00
China SXT Pharmaceuticals (SXTC)	China	$0.012B	0.00
Addex Therapeutics (ADXN)	Switzerland	$0.011B	0.00
Curanex Pharmaceuticals Inc (CURX)	United States	$0.010B	0.00
Mangoceuticals (MGRX)	United States	$0.010B	0.00
Ernexa Therapeutics (ERNA)	United States	$0.010B	0.00
BioVie (BIVI)	United States	$0.010B	0.00
XTL Biopharmaceuticals (XTLB)	Israel	$0.009B	0.00
Nuvilex (PMCB)	United States	$0.009B	0.00
Ainos (AIMD)	United States	$0.009B	0.00
Quoin Pharmaceuticals (QNRX)	United States	$0.009B	0.00
Kiora Pharmaceuticals (KPRX)	United States	$0.008B	0.00
Biomerica (BMRA)	United States	$0.008B	0.00
Salarius Pharmaceuticals (DCOY)	United States	$0.008B	0.00
TransCode Therapeutics (RNAZ)	United States	$0.008B	0.00
Heatwurx (PCSA)	United States	$0.007B	0.00
Aptorum Group (APM)	United Kingdom	$0.007B	0.00
Indaptus Therapeutics (INDP)	United States	$0.006B	0.00
Redhill Biopharma (RDHL)	Israel	$0.006B	0.00
Alaunos Therapeutics (TCRT)	United States	$0.006B	0.00
Sonoma Pharmaceuticals (SNOA)	United States	$0.006B	0.00
Xenetic Biosciences (XBIO)	United States	$0.005B	0.00
Salarius Pharmaceuticals (SLRX)	United States	$0.005B	0.00
XORTX Therapeutics (XRTX)	Canada	$0.004B	0.00
Clearmind Medicine (CMND)	Canada	$0.004B	0.00
Lyra Therapeutics (LYRA)	United States	$0.004B	0.00
InMed Pharmaceuticals (INM)	Canada	$0.003B	0.00
Jaguar Animal Health (JAGX)	United States	$0.003B	0.00
Universe Pharmaceuticals INC (UPC)	China	$0.002B	0.00
Shuttle Pharmaceuticals Holdings (SHPH)	United States	$0.002B	0.00
CDT Equity (CDT)	United States	$0.002B	0.00
60 Degrees Pharmaceuticals (SXTP)	United States	$0.002B	0.00
PainReform (PRFX)	Israel	$0.002B	0.00
Galmed Pharmaceuticals (GLMD)	Israel	$0.001B	0.00
SciSparc (SPRC)	Israel	$0.001B	0.00
Aditxt (ADTX)	United States	$0.001B	0.00
Emisphere Technologies (EMIS)	United States	$0.000B	0.00
4D Pharma (LBPS)	United Kingdom	$0.000B	0.00
Patheon (PTHN)	Netherlands	$0.000B	0.00
RVL Pharmaceuticals (RVLP)	United States	$0.000B	0.00